Cite
Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
MLA
Kathryn P. Moore, et al. “Testosterone Treatment and the Risk of Aggressive Prostate Cancer in Men with Low Testosterone Levels.” PLoS ONE, vol. 13, no. 6, Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48c8e14b5a03bc79ce83e33260e222c1&authtype=sso&custid=ns315887.
APA
Kathryn P. Moore, Thomas J. Walsh, Chloe Krakauer, Susan R. Heckbert, Anna Korpak, Alvin M. Matsumoto, Christopher W. Forsberg, Nicholas L. Smith, Steven B. Zeliadt, Mary Lou Thompson, Molly M. Shores, Chloe E. Kinsey, & Alexandra E. Fox. (2018). Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels. PLoS ONE, 13(6).
Chicago
Kathryn P. Moore, Thomas J. Walsh, Chloe Krakauer, Susan R. Heckbert, Anna Korpak, Alvin M. Matsumoto, Christopher W. Forsberg, et al. 2018. “Testosterone Treatment and the Risk of Aggressive Prostate Cancer in Men with Low Testosterone Levels.” PLoS ONE 13 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....48c8e14b5a03bc79ce83e33260e222c1&authtype=sso&custid=ns315887.